Tune in to this episode of Endpoints Webinars featuring Forge's David Dismuke, Ph.D., Chief Technical Officer, and John Maslowski, Chief Commercial Officer.
A strong partnership between gene therapy developers and their CDMOs is paramount for any program’s success. What questions can help strengthen collaboration and alignment during the development and manufacturing process? Hear from leading gene therapy developers and Forge's experts as they delve into the key questions they’re asking their CDMO partners around yield, commercial readiness, validated scale-down models, automation of analytical assays, and more.
Listen here.